A patient registry for COPD research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The COPD Patient-Powered Research Network (COPD PPRN) aims to enroll over 75,000 patients with Chronic Obstructive Pulmonary Disease (COPD) and those at risk, allowing them to share their health information over several years. This observational study utilizes an online platform for volunteers to enroll, complete surveys, and be contacted about qualifying research studies. The primary goal is to accelerate research efforts to discover better treatments and ultimately find a cure for COPD.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* 18 years or older that says yes to one of the following:
* COPD diagnosis
* Current or former smoker
* Family history of respiratory disease
* Symptomatic of respiratory disease

Exclusion Criteria:

* Non-English speaking

Where it's running

• COPD Foundation
  Washington D.C., District of Columbia, United States Recruiting

Study contacts

• Study coordinator: Gretchen M McCreary, MA
• Email: gmccreary@copdfoundation.org
• Phone: 866-731-2673

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Registry for patients with emphysema and COPD

  This study is collecting information from people with emphysema and COPD to help researchers learn more about these lung diseases and improve future treatments.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT00307281

• Xenon MRI test for lung changes after Apreo BREATHE airway treatment in emphysema

  This study tests whether hyperpolarized Xenon MRI can show regional ventilation and gas-exchange changes after the Apreo BREATHE airway scaffolds in people with emphysema and air trapping.

  Recruiting Early Phase 1 Apreo Health, Inc. · Birmingham, Alabama and 1 other locations · NCT07896902

• Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency

  This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.

  Recruiting at 4 sites University Hospital, Bordeaux · Bron and 3 other locations · NCT07715617

• Singing training versus usual care after lung cancer surgery (6–18 months post-operation)

  This trial will test whether an online singing program can help people who had surgery for early-stage non-small cell lung cancer 6–18 months ago feel better, breathe easier, and improve physical fitness.

  Recruiting at 5 sites Zealand University Hospital · Copenhagen and 4 other locations · NCT07460999

• Testing CE1226 doses to slow lung disease in adults with alpha-1 antitrypsin deficiency

  This trial tests two active doses of CE1226 to see if they slow lung density decline in adults with AAT deficiency and emphysema over 3 years compared with the standard 60 mg/kg dose.

  Recruiting at 2 sites Phase 4 CSL Behring · Aalborg and 1 other locations · NCT07326592

• Implant to help adults with severe emphysema

  This study will test whether an implantable artificial bronchus can improve breathing and safety in adults with severe COPD/emphysema.

  Recruiting at 4 sites Pulmair Medical, Inc. · San Francisco, California and 3 other locations · NCT07119229

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.